Audiovisual accessibility is no longer an emerging trend in the healthcare sector. Since 2025, it has become a strategic imperative.
The entry into force of the European Accessibility Act (EAA) has fundamentally reshaped the landscape for pharmaceutical, biotechnology and MedTech companies operating across Europe. What was once viewed as a user-experience enhancement now sits at the core of digital compliance, multilingual content strategy and effective market access.
At a time when video has become the dominant format for communicating scientific innovation, educating patients and supporting therapeutic launches, audiovisual accessibility is redefining how organisations design and localise their global communications.
The impact of the European Accessibility Act (EAA 2025) on healthcare audiovisual content
The European Accessibility Act introduces clear obligations for digital service providers, including requirements for multimedia content to be accessible across websites, health platforms and mobile applications. For healthcare organisations, this means that corporate videos, patient education materials and medical communications must incorporate features that enable understanding among people with hearing or cognitive impairments.
In practical terms, accessible subtitling — commonly referred to as SDH (Subtitles for the Deaf and Hard of Hearing) — is moving from a voluntary best practice to a regulatory requirement. This involves not only transcribing spoken content, but also capturing relevant contextual information such as background sounds, speaker changes and nuances in tone.
More broadly, audiovisual accessibility is closely linked to equity in access to health information. Ensuring that content is understandable to diverse audiences contributes to improved health literacy and helps strengthen trust in healthcare brands.
The multilingual challenge: accessibility beyond translation
One of the most complex aspects of complying with the EAA in the healthcare sector is its multilingual dimension. Companies operate in highly fragmented linguistic and regulatory markets, requiring audiovisual content to be adapted into multiple languages without compromising scientific accuracy or terminological consistency.
In this context, accessibility cannot be treated as a simple technical layer added at the end of the production process. It must be embedded within the overall audiovisual localisation strategy. This involves:
- Developing accessible subtitles that are culturally and linguistically adapted to each target market
- Validating medical terminology in line with local regulatory guidance
- Adjusting subtitle length and readability according to audience reading speed
- Ensuring consistency between audio, visuals and on-screen text across different language versions
Such an approach helps prevent common pitfalls, including overly literal translations, loss of clinical nuance or subtitle density that hinders comprehension.
Accessibility as a competitive advantage in healthcare communication
Beyond regulatory compliance, audiovisual accessibility can become a meaningful differentiator for organisations in the healthcare sector. Accessible content tends to enhance user experience, improve message retention and extend the reach of digital campaigns across multiple channels.
Multilingual subtitles also support video consumption in environments where audio is not always practical — such as hospitals, conferences, pharmacies or other public settings — while contributing to stronger organic visibility across search engines and professional platforms.
Integrating accessibility from the earliest stages of content planning allows organisations to optimise resources, mitigate regulatory risk and ensure that medical information reaches all stakeholders clearly and safely, including healthcare professionals, patients, distributors and regulatory authorities.
Accessibility by design: embedding inclusion from the outset
As digital healthcare ecosystems continue to grow in complexity, leading organisations are moving towards “accessible-by-design” audiovisual production models. This means incorporating accessibility, multilingual localisation and regulatory compliance considerations from the initial content concept phase, rather than addressing them only during later technical adaptation stages.
Planning for accessibility from the outset enables faster time-to-market, reduces costs associated with revisions and ensures greater consistency across pan-European campaigns. In Life Sciences, where audiovisual materials often combine clinical information, complex visuals and sensitive regulatory messaging, this proactive approach is particularly valuable.
Furthermore, the ongoing digitalisation of interactions with patients and healthcare professionals is expanding the range of touchpoints where audiovisual content must be accessible — including patient portals, therapy support platforms, hybrid events, adherence apps and health education programmes. Designing videos that can be understood across different linguistic, cultural and technological contexts is rapidly becoming a strategic capability for marketing, medical affairs and corporate communications teams.
Towards an inclusive, scalable and future-ready audiovisual strategy
The European Accessibility Act does not represent a one-off regulatory obligation, but rather the beginning of a structural shift in how the healthcare sector approaches digital communication. Audiovisual accessibility is emerging as a new benchmark for quality, closely linked to trust, transparency and corporate social responsibility.
Organisations that adopt a long-term perspective — integrating accessibility, multilingual localisation and scientific excellence into their content strategies — will be better positioned to navigate an increasingly demanding regulatory environment and a highly competitive global market.
Investing in accessible audiovisual content today not only supports compliance with European legislation, but also strengthens organisations’ ability to engage authentically with diverse audiences, improve understanding of medical information and reinforce their positioning as champions of inclusive innovation.
In a sector where effective communication can directly influence patient experience and safety, audiovisual accessibility is no longer just a technical requirement — it is becoming a genuine strategic advantage.
Are you planning to adapt medical or corporate video content for multiple European markets?
